Bio-Reference Laboratories, Inc. (NASDAQ:BRLI)

CAPS Rating: 4 out of 5

An independent clinical laboratory servicing the New York metropolitan area that offers a comprehensive list of laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases.

Recs

0
Player Avatar ICTOptimist (31.51) Submitted: 3/26/2011 6:44:32 PM : Outperform Start Price: $22.33 BRLI Score: -9.13

Favorable demographics, smaller company than industry's largest with better growth or acquisition prospects.

Featured Broker Partners


Advertisement